Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by nodaytraderon Dec 27, 2022 2:17pm
77 Views
Post# 35192636

RE:RE:RE:Fact or Fiction?

RE:RE:RE:Fact or Fiction?

There's a lot I don't know.

I don't know who Chris Temple is. I didn't know if he's been convicted of anything-you said that he's charged and imprisoned but, if that's it, he is still innocent.

i don't know where you get your information from and I do  it know what a Neo-nazi is, apart from being a vague term of abuse

what I do know is just because something is written down does not make it correct.

I also know that the mainstream media have shown themselves as unreliable.

These are the folks who, for 56 years (let that sink in) have been predicting climate doom when all these predictions turned out to be dead wrong. The Maldives have not disappeared, nor have the glaciers, there have not been famines that killed hundreds of millions, and New York was not under 20 feet of water by February 2016.

they also told us that Hilary Clinton was a shoo-in. For years they told us that Trump was colluding with Russians, and that millions would die in 2020 from Covid. As it turned out, there is no evidence of excess mortality anywhere in the world in that year; neither the FBI, nor the Mueller investigation, nor the Senate Internet committee could find evidence of the alleged collusion, and Clinton won very few counties, one report was 57 out of 3,141.

so, I would not rely on those sources for anything.

As for Algernon, what we know is that it has always had the goal of presenting as an attractive potential acquisition or licensor to big Pharma. We also know that an acquiring company looks at imputed value and share price. The greater the difference between imputedvalue value and share price value, the more attractive the target acquisition.

We also know that Algernon has substantial imputed value and that Big Pharma is in touch with Algernon.

what we don't know is exactly who, or what was discussed, For all we know, significant discussions may have already taken place but they are usually confidential.
 

I am stil confidently optimistic and will be patient.
 

<< Previous
Bullboard Posts
Next >>